Home / Data / Recall & Adverse Event Monitor Recall & Adverse Event Monitor Recall & Adverse Event Monitor organizes records from openFDA API into a static ledger for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 2,000
Last changed 08/30/2026
Update schedule 28 2 * * 4 UTC
Coverage 06/30/2026–06/30/2026 2026-06-30
Title BENRALIZUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ELIQUIS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title METHYLPHENIDATE HYDROCHLORIDE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title REPATHA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ACALABRUTINIB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title REVLIMID
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OSIMERTINIB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title METHYLPREDNISOLONE ACETATE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title BENRALIZUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title UPTRAVI
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title RINVOQ
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title CREON
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title PREGABALIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ASFOTASE ALFA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title SKYRIZI
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title REVLIMID
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OZEMPIC
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title METFORMIN HYDROCHLORIDE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ERLEADA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title GLOFITAMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title RINVOQ
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title HIZENTRA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title INVEGA SUSTENNA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TACROLIMUS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ADALIMUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ZEPBOUND KWIKPEN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OLMESARTAN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TRELSTAR
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title GEMCITABINE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24 Source U.S. Food and Drug Administration, openFDA API · official record · retrieved 08/30/2026 · upstream last modified 08/30/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. Food and Drug Administration
Required notice Reports do not prove causation and are not medical advice, diagnosis, or an assessment of individual risk. What we add We compute Event Classification, Age Or Deadline Days, Public Significance Score using the documented compute method. · methodology